C-ZOCAIN

This brand name is authorized in Nigeria.

Active ingredients

The drug C-ZOCAIN contains one active pharmaceutical ingredient (API):

1	Lidocaine UNII V13007Z41A - LIDOCAINE HYDROCHLORIDE
	Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.
	Read more about Lidocaine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-2241	Injection	C-Zocain Injection INJ 2% 10 x 1 x 50 mL (in glass vials)	Liquid Injection A clear and colorless solution filled in an intactly sealed amber glass vial 185 CMS-PP-337716 C-ZOCAIN INJECTION LIDOCAINE INJECTION BP 2%W/V Each ml contain: Lidocaine Hydrochloride Monohydrate BP 21.33mg eq. to Lidocaine Hydrochloride 20mg, Sodium Chloride BP 6.0mg, Methyl Paraben BP (as preservative) 1.0mg, Water for Injection BP q.s. B4-2241 Drugs Imported Products 10150ml Prescription Only Medicine (POM) 6/16/2023 CHEZ RESOURCES PHARMACEUTICAL LIMITED, 7 CALABAR STREET FEGGE ONITSHA ANAMBRA 46485780 chezrespharm@gmail.com NITIN LIFESCIENCES LTD. , 92-93, Sector-3, H. S. I. D. C., INDUSTRIAL AREA, KARNAL-132001, HARYANA, INDIA, India	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N01BB02	Lidocaine	N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-2241